![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Edwards Lifesciences Earns CE Mark for CENTERA Valve
Edwards Lifesciences Earns CE Mark for CENTERA Valve
![Edwards Lifesciences logo](https://www.fdanews.com/ext/resources/test/Device_Images5/EdwardsLifesciences_Logo.gif?t=1622667039&width=430)
February 16, 2018
Edwards Lifesciences received a CE Mark for its self-expanding CENTERA valve for severe, symptomatic aortic stenosis patients at high risk of open-heart surgery.
The valve is repositionable and retrievable and can be delivered through a motorized delivery system.
The CE Mark was based on the trial results from a study of 203 high-risk patients at 23 centers in Europe, Australia and New Zealand.
Upcoming Events
-
21Oct